Recombinant IL-1Ra as first-line therapy in sJIA

Recombinant IL-1Ra as first-line therapy in sJIARecombinant IL-1Ra as first-line therapy in sJIA, Published online: 27 March 2019; doi:10.1038/s41584-019-0208-8Recombinant IL-1Ra as first-line therapy in sJIA
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Source Type: research
More News: Rheumatology